Syschem (India) Ltd

Syschem (India) Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Syschem (India) Ltd

₹ 43.2 1.62%
22 May - close price
syschem.in BSE: 531173
About

Incorporated in 1993, Syschem (India) Limited manufactures Active Pharmaceuticals Ingredients (APIs) and bulk drugs.

Key Points

Product Profile:[1]
API/ Intermediates:
a) Amoxycillin Tri Hydrate
b) Ampicillin Tri Hydrate
c) Cloxacillin Sodium
d) Dicloxacillin Sodium
e) Flucloxacillin Sodium (For export only)
f) Cephalexin
g) Cefixime
h) Cefadroxil
i) Distillation of Specialty Solvents –
DMF, Acetonitrile, Ethyl Acetate and THF

Website BSE
  • Market Cap ₹ 188 Cr.
  • Current Price ₹ 43.2
  • High / Low ₹ 56.0 / 35.3
  • Stock P/E 409
  • Book Value ₹ 21.0
  • Dividend Yield 0.00 %
  • ROCE 1.45 %
  • ROE 0.62 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Promoter holding has increased by 3.85% over last quarter.
  • Company's median sales growth is 40.0% of last 10 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 6.02% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
20.08 15.10 20.02 29.52 48.91 43.10 37.11 43.74 74.71 87.53 47.52 77.76 118.87
17.21 13.75 18.08 26.68 46.39 40.65 35.26 42.66 73.09 86.72 47.45 76.56 116.97
Operating Profit 2.87 1.35 1.94 2.84 2.52 2.45 1.85 1.08 1.62 0.81 0.07 1.20 1.90
OPM % 14.29% 8.94% 9.69% 9.62% 5.15% 5.68% 4.99% 2.47% 2.17% 0.93% 0.15% 1.54% 1.60%
0.06 0.05 0.13 0.01 0.06 0.00 0.00 0.01 0.15 0.01 0.00 0.02 0.02
Interest 0.22 0.01 0.02 0.06 -0.04 0.10 0.03 0.11 0.01 0.00 0.03 0.04 0.00
Depreciation 0.69 0.68 0.71 0.71 0.59 0.68 0.70 0.74 0.67 0.68 0.68 0.68 0.91
Profit before tax 2.02 0.71 1.34 2.08 2.03 1.67 1.12 0.24 1.09 0.14 -0.64 0.50 1.01
Tax % -23.27% 0.00% 0.00% 0.00% 80.79% 0.00% 0.00% 0.00% 123.85% 0.00% 0.00% 0.00% 54.46%
2.49 0.71 1.34 2.07 0.39 1.68 1.12 0.23 -0.26 0.14 -0.64 0.50 0.46
EPS in Rs 0.86 0.19 0.35 0.52 0.10 0.42 0.28 0.06 -0.07 0.04 -0.16 0.13 0.11
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
18 11 4 13 67 93 77 68 59 114 199 332
14 14 5 12 63 89 77 73 58 105 192 328
Operating Profit 4 -3 -1 0 3 4 -0 -5 1 9 7 4
OPM % 22% -23% -24% 0% 5% 4% -0% -7% 1% 8% 4% 1%
1 0 0 -0 -0 -0 0 -0 0 0 0 0
Interest 3 1 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 2 2 3 3 3 3
Profit before tax 1 -5 -3 -2 1 2 -2 -7 -2 6 4 1
Tax % 21% -26% -27% -30% 43% 50% -16% -24% -22% 27% 33% 54%
1 -4 -2 -1 0 1 -2 -6 -2 5 3 0
EPS in Rs 0.30 -1.94 -1.13 -0.75 0.17 0.32 -0.79 -2.07 -0.59 1.13 0.69 0.11
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 40%
5 Years: 34%
3 Years: 78%
TTM: 67%
Compounded Profit Growth
10 Years: 8%
5 Years: 18%
3 Years: 31%
TTM: -83%
Stock Price CAGR
10 Years: 18%
5 Years: 49%
3 Years: 41%
1 Year: -16%
Return on Equity
10 Years: -2%
5 Years: 1%
3 Years: 6%
Last Year: 1%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 16 16 16 16 16 19 19 22 23 32 40 44
Reserves -2 -6 -8 -10 -8 -8 -10 -15 -16 -10 17 48
32 28 27 22 20 16 17 16 2 2 0 0
9 13 12 16 29 35 36 55 51 69 107 126
Total Liabilities 55 51 47 44 58 62 62 77 60 93 164 217
36 34 32 30 29 27 28 30 32 31 31 53
CWIP 0 1 1 1 0 0 1 1 0 0 4 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
18 16 15 14 28 35 34 46 28 62 129 164
Total Assets 55 51 47 44 58 62 62 77 60 93 164 217

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
4 1 0 6 0 -2 3 4 1 -8 -26 -10
-3 0 0 0 0 2 -4 -4 -1 -2 -6 -22
-1 -2 -1 -7 -0 -0 -0 -0 -0 11 32 34
Net Cash Flow 0 -1 0 -0 0 0 -0 -0 0 1 -0 2

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 143 187 272 124 47 21 47 31 21 135 126 99
Inventory Days 280 228 868 182 80 104 110 199 152 61 107 81
Days Payable 183 290 870 424 151 131 175 221 186 158 198 143
Cash Conversion Cycle 240 124 271 -119 -24 -7 -19 9 -14 38 34 36
Working Capital Days 120 72 92 -173 -23 -12 -24 13 -15 48 54 39
ROCE % 8% -11% -8% -6% 3% 7% -8% -29% -12% 38% 11% 1%

Shareholding Pattern

Numbers in percentages

7 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Apr 2025
21.78% 52.10% 53.82% 53.82% 53.82% 53.79% 53.89% 53.89% 53.89% 53.17% 53.17% 57.02%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.14% 0.25% 0.25% 0.20% 0.20% 0.18%
78.22% 47.90% 46.18% 46.19% 46.19% 46.21% 45.97% 45.86% 45.87% 46.63% 46.63% 42.79%
No. of Shareholders 8,3709,3189,16710,18110,32912,18612,57113,94213,31013,30513,44513,223

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • May 2025
    Transcript
    Notes
    PPT
  • May 2023
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT
  • Jul 2022
    Transcript
    Notes
    PPT